HADI M. YASSINE

Cited by

	All	Since 2019
Citations	18548	16540
h-index	65	61
i10-index	179	170

4900

2450

1225

3675

20102011201220132014201520162017201820192020202120222023202459 56 99 150 181 189 335 353 439 522 1330 2994 4823 3998 2727

Public access

View all

26 articles

0 articles

available

not available

Based on funding mandates

Co-authors

Prof. Gheyath K. NasrallahProfessor of Biomedical Science, College of Health Sciences, QU health, Qatar UniversityVerified email at qu.edu.qa
Hebah Al KhatibResearch associate, Qatar UniversityVerified email at qu.edu.qa
Maria K. SmattiQatar UniversityVerified email at qu.edu.qa
Masaru KanekiyoVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of HealthVerified email at nih.gov
Duaa Al-SadeqFunctional Genomics and Proteomics, Qatar UniversityVerified email at qu.edu.qa
nadin younesPhD Candidate, Qatar UniversityVerified email at qu.edu.qa
Nahla O EltaiQatar UniversityVerified email at qu.edu.qa
Kizzmekia S. Corbett-HelaireHarvard T.H. Chan School of Public HealthVerified email at hsph.harvard.edu
Syed M. MoinScientific Review Officer, National Institutes of Health, Bethesda, USAVerified email at nih.gov
M. Gordon Joyce, PhDChief, Structural Biology, HJF, WRAIRVerified email at eidresearch.org
Adrian B McDermottChief, Vaccine Immunology Program, Vaccine Research Center, NIAID-NIHVerified email at nih.gov
Jason S. McLellanProfessor of Molecular BiosciencesVerified email at austin.utexas.edu
Adam WheatleyUniversity of MelbourneVerified email at unimelb.edu.au
Mutasem El-FadelAmerican University of BeirutVerified email at aub.edu.lb
Steve HarakehKing Fahd Medical Research Center, King Abdulaziz UniversityVerified email at kau.edu.sa
Nianshuang Wang (王年爽)Research FellowVerified email at utexas.edu
Jesper PallesenIndiana University BloomingtonVerified email at pallesen.info
Hannah L TurnerThe Scripps Research InstituteVerified email at scripps.edu
Robert N. KirchdoerferUniversity of Wisconsin-MadisonVerified email at wisc.edu
Christopher A CottrellThe Scripps Research InstituteVerified email at scripps.edu

HADI M. YASSINE

Section Head of Research, Associate Professor of Infectious Diseases, IBC chair, Qatar University

Verified email at QU.edu.qa

Virology Immunology and Vaccinology


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Effectiveness of the BNT162b2 Covid-19 Vaccine against the B. 1.1. 7 and B. 1.351 Variants LJ Abu-Raddad, H Chemaitelly, AA Butt New England Journal of Medicine 385 (2), 187-189, 2021	1122	2021
Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar H Chemaitelly, P Tang, MR Hasan, S AlMukdad, HM Yassine, ... New England Journal of Medicine 385 (24), e83, 2021	912	2021
Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies M Kanekiyo, CJ Wei, HM Yassine, PM McTamney, JC Boyington, ... Nature 499 (7456), 102-106, 2013	901	2013
Pre-fusion structure of a human coronavirus spike protein RN Kirchdoerfer, CA Cottrell, N Wang, J Pallesen, HM Yassine, HL Turner, ... Nature 531 (7592), 118-121, 2016	860	2016
Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection HM Yassine, JC Boyington, PM McTamney, CJ Wei, M Kanekiyo, ... Nature medicine 21 (9), 1065-1070, 2015	687	2015
Effects of previous infection and vaccination on symptomatic omicron infections HN Altarawneh, H Chemaitelly, HH Ayoub, P Tang, MR Hasan, ... New England Journal of Medicine 387 (1), 21-34, 2022	510	2022
Viruses and autoimmunity: a review on the potential interaction and molecular mechanisms MK Smatti, FS Cyprian, GK Nasrallah, AA Al Thani, RO Almishal, ... Viruses 11 (8), 762, 2019	503	2019
BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar P Tang, MR Hasan, H Chemaitelly, HM Yassine, FM Benslimane, ... Nature medicine 27 (12), 2136-2143, 2021	478	2021
Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines Q Fernandes, VP Inchakalody, M Merhi, S Mestiri, N Taib, ... Annals of medicine 54 (1), 524-540, 2022	456	2022
Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2 N Younes, DW Al-Sadeq, H Al-Jighefee, S Younes, O Al-Jamal, HI Daas, ... Viruses 12 (6), 582, 2020	452	2020
Protection against the Omicron variant from previous SARS-CoV-2 infection HN Altarawneh, H Chemaitelly, MR Hasan, HH Ayoub, S Qassim, ... New England Journal of Medicine 386 (13), 1288-1290, 2022	436	2022
mRNA-1273 COVID-19 vaccine effectiveness against the B. 1.1. 7 and B. 1.351 variants and severe COVID-19 disease in Qatar H Chemaitelly, HM Yassine, FM Benslimane, HA Al Khatib, P Tang, ... Nature medicine 27 (9), 1614-1621, 2021	421	2021
Prefusion F–specific antibodies determine the magnitude of RSV neutralizing activity in human sera JO Ngwuta, M Chen, K Modjarrad, MG Joyce, M Kanekiyo, A Kumar, ... Science translational medicine 7 (309), 309ra162-309ra162, 2015	404	2015
Effect of mRNA vaccine boosters against SARS-CoV-2 Omicron infection in Qatar LJ Abu-Raddad, H Chemaitelly, HH Ayoub, S AlMukdad, HM Yassine, ... New England Journal of Medicine 386 (19), 1804-1816, 2022	397	2022
Evaluation of candidate vaccine approaches for MERS-CoV L Wang, W Shi, MG Joyce, K Modjarrad, Y Zhang, K Leung, CR Lees, ... Nature communications 6 (1), 7712, 2015	342	2015
Vaccine-induced antibodies that neutralize group 1 and group 2 influenza A viruses MG Joyce, AK Wheatley, PV Thomas, GY Chuang, C Soto, RT Bailer, ... Cell 166 (3), 609-623, 2016	329	2016
Structural and genetic basis for development of broadly neutralizing influenza antibodies D Lingwood, PM McTamney, HM Yassine, JRR Whittle, X Guo, ... Nature 489 (7417), 566-570, 2012	302	2012
Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses M Kanekiyo, MG Joyce, RA Gillespie, JR Gallagher, SF Andrews, ... Nature immunology 20 (3), 362-372, 2019	269	2019
Assessment of the risk of SARS-CoV-2 reinfection in an intense re-exposure setting Clinical Infectious Diseases, 2020	244*	2020
Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA. 1 and BA. 2 subvariants in Qatar H Chemaitelly, HH Ayoub, S AlMukdad, P Coyle, P Tang, HM Yassine, ... Nature communications 13 (1), 3082, 2022	240	2022

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors